• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment outcomes of MDR-TB and HIV co-infection in Europe.

作者信息

Magis-Escurra Cecile, Günther Gunar, Lange Christoph, Alexandru Sofia, Altet Neus, Avsar Korkut, Bang Didi, Barbuta Raisa, Bothamley Graham, Ciobanu Ana, Crudu Valeriu, Davilovits Manfred, Dedicoat Martin, Duarte Raquel, Gualano Gina, Kunst Heike, de Lange Wiel, Leimane Vaira, McLaughlin Anne-Marie, Muylle Inge, Polcová Veronika, Popa Christina, Rumetshofer Rudolf, Skrahina Alena, Solodovnikova Varvara, Spinu Victor, Tiberi Simon, Viiklepp Piret, van Leth Frank

机构信息

Radboud University Medical Centre - TB Expert Centre UCCZ Dekkerswald, Nijmegen-Groesbeek, The Netherlands.

These authors contributed equally to this article.

出版信息

Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.02363-2016. Print 2017 Jun.

DOI:10.1183/13993003.02363-2016
PMID:28596434
Abstract
摘要

相似文献

1
Treatment outcomes of MDR-TB and HIV co-infection in Europe.欧洲耐多药结核病与艾滋病病毒合并感染的治疗结果
Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.02363-2016. Print 2017 Jun.
2
Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe.东欧 HIV 阳性患者中的耐多药结核病。
J Infect. 2014 Mar;68(3):259-63. doi: 10.1016/j.jinf.2013.09.034. Epub 2013 Nov 16.
3
HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.HIV 阳性患者接受耐多药结核病治疗：HAART 时代的临床结局。
Int J Tuberc Lung Dis. 2012;16(3):348-54. doi: 10.5588/ijtld.11.0473.
4
Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.HIV 感染者与 HIV 非感染者耐药结核病治疗结局的比较：多中心队列研究。
PLoS One. 2018 Mar 8;13(3):e0193491. doi: 10.1371/journal.pone.0193491. eCollection 2018.
5
Multidrug-resistant tuberculosis in an HIV-infected girl.一名感染艾滋病毒女孩的耐多药结核病
Natl Med J India. 2012 Jul-Aug;25(4):210-1.
6
Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.南非耐多药结核病-人类免疫缺陷病毒合并感染患者的同步治疗可提高生存率和治愈率。
Clin Infect Dis. 2018 Apr 3;66(8):1246-1253. doi: 10.1093/cid/cix1125.
7
Potential drug-drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals.抗逆转录病毒治疗与耐多药结核病治疗方案之间的潜在药物相互作用：对合并耐多药结核病的 HIV 感染者的 HIV 护理的影响。
Int J Infect Dis. 2019 Jun;83:98-101. doi: 10.1016/j.ijid.2019.04.009. Epub 2019 Apr 13.
8
Is Multi-Drug Resistant Tuberculosis More Prevalent in HIV-Infected Patients in Korea?多重耐药结核病在韩国艾滋病毒感染患者中更普遍吗？
Yonsei Med J. 2016 Nov;57(6):1508-10. doi: 10.3349/ymj.2016.57.6.1508.
9
Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.在哈萨克斯坦，HIV 感染与耐多药结核病之间虽存在趋同的风险因素，但并无关联。
Int J Tuberc Lung Dis. 2013 Apr;17(4):526-31. doi: 10.5588/ijtld.12.0703.
10
Treatment Outcomes of Children With HIV Infection and Drug-resistant TB in Three Provinces in South Africa, 2005-2008.2005 - 2008年南非三省感染艾滋病毒且患耐药结核病儿童的治疗结果
Pediatr Infect Dis J. 2017 Dec;36(12):e322-e327. doi: 10.1097/INF.0000000000001691.

引用本文的文献

1
Characterizing Musculoskeletal and Neurological Toxicities Associated With the BPaLM Regimen: A Clinical Evaluation of Arthralgia and Peripheral Neuropathy in Patients With Multidrug-Resistant Tuberculosis (MDR-TB).表征与BPaLM方案相关的肌肉骨骼和神经毒性：耐多药结核病（MDR-TB）患者关节痛和周围神经病变的临床评估
Cureus. 2025 Jun 17;17(6):e86248. doi: 10.7759/cureus.86248. eCollection 2025 Jun.
2
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study.意大利南部某地区本地人和外国出生人口中的结核病与耐药性：一项基于省份的十二年研究。
J Clin Tuberc Other Mycobact Dis. 2025 Jan 27;38:100512. doi: 10.1016/j.jctube.2025.100512. eCollection 2025 Feb.
3
Radiographic characteristics of rifampicin-resistant tuberculosis in the STREAM stage 1 trial and their influence on time to culture conversion in the short regimen.STREET 阶段 1 试验中利福平耐药结核病的放射学特征及其对短程方案中培养物转换时间的影响。
BMC Infect Dis. 2024 Jan 30;24(1):144. doi: 10.1186/s12879-024-09039-z.
4
Successful outcomes for patients with drug-resistant tuberculosis despite civil unrest and COVID-19 in Haiti.尽管海地发生内乱和新冠疫情，但耐药结核病患者仍取得成功治疗结果。
PLOS Glob Public Health. 2023 Sep 12;3(9):e0002356. doi: 10.1371/journal.pgph.0002356. eCollection 2023.
5
Efficacy of single-stage posterior surgery for HIV-positive patients with thoracolumbar tuberculosis.一期后路手术治疗 HIV 阳性合并胸腰椎结核的疗效。
AIDS Res Ther. 2022 Nov 22;19(1):53. doi: 10.1186/s12981-022-00478-9.
6
Factors associated with treatment outcomes of patients with drug-resistant tuberculosis in China: A retrospective study using competing risk model.中国耐多药结核病患者治疗结局相关因素的回顾性研究：采用竞争风险模型。
Front Public Health. 2022 Sep 7;10:906798. doi: 10.3389/fpubh.2022.906798. eCollection 2022.
7
Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB.STREAM 阶段 1 短程方案治疗 RR-TB 的失败或复发预测因素。
Int J Tuberc Lung Dis. 2022 Aug 1;26(8):753-759. doi: 10.5588/ijtld.22.0073.
8
Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study.影响印度尼西亚西爪哇地区长程耐药结核病治疗结局的因素：一项回顾性队列研究。
PLoS One. 2021 Feb 8;16(2):e0246284. doi: 10.1371/journal.pone.0246284. eCollection 2021.
9
Treatment outcomes of drug resistant tuberculosis patients with multiple poor prognostic indicators in Uganda: A countrywide 5-year retrospective study.乌干达具有多种不良预后指标的耐多药结核病患者的治疗结果：一项全国性5年回顾性研究
J Clin Tuberc Other Mycobact Dis. 2021 Jan 27;23:100221. doi: 10.1016/j.jctube.2021.100221. eCollection 2021 May.
10
Chronic Immune Activation in TB/HIV Co-infection.结核分枝杆菌/人类免疫缺陷病毒合并感染中的慢性免疫激活。
Trends Microbiol. 2020 Aug;28(8):619-632. doi: 10.1016/j.tim.2020.03.015. Epub 2020 Apr 22.